Superpower is best when you want a broad, all-in-one consumer health platform — 100+ biomarkers (as advertised), data uploads, wearable connections, protocols and an AI chat in one place. AMORTAL is different — not a platform. It takes whatever results you have and turns them into one auditable next best action, a watchlist, and an outcome loop.
Superpower built one of the broadest consumer-health memberships available: a wide biomarker panel (it advertises 100+), the ability to upload external health data, wearable connections, a biological-age readout, protocols, an AI chat, and care-team access — with add-on tests and access to supplements and peptides layered on top. It answers the question “what’s going on across my health data?” in one place, well.
What a broad platform and an AI chat don’t give you is an auditable decision — one change written down in advance, with the signal to watch and the window to see it, then checked against the next result. That’s the gap this page is about. Below is a fair, source-backed look at what Superpower is excellent for, and where AMORTAL fits as the decision layer on top. It’s educational, not medical advice.
+
Use Superpower for the data. Use AMORTAL to decide what the data should change, what to ignore, what to watch, and when to retest.
The short version: who each is for
These two aren’t really competitors — one is the platform that gathers the data, the other decides what to do with it. Here’s the honest split.
Which one fits which job
SuperpowerBest for a broad health platformA broad, all-in-one consumer-health platform — a wide biomarker panel, uploaded health data, wearable connections, a biological-age readout, protocols, an AI chat and care-team access. Strongest when you want everything gathered and visible in one place.
AMORTALBest for deciding what to do nextNot a platform. A longitudinal decision layer that reads whatever results you already have — from Superpower or anywhere — and returns one ranked next action, a watchlist, a clinician-ready question, and an outcome loop. Including when to do nothing.
This isn't an "A beats B." Superpower gathers and shows what's going on; AMORTAL decides what it should change. The strongest setup uses both.
Superpower vs AMORTAL, at a glance
Tap between the two to see what each is actually responsible for.
What each one owns
Same goal — better decisions from your health data — split into the platform job and the decision job.
The platform layer
Superpower runs a broad consumer-health membership — a wide panel (it advertises 100+ biomarkers), external data upload, wearable connections, a biological-age readout, protocols, an AI chat and care-team access, with add-on tests and supplements/peptides available.
You want your testing, uploads and wearable context gathered, scored and visible in one place, with a chat to ask questions. Verify the current marker count, price and what the care team includes before you buy.
The decision layer
AMORTAL doesn't run a platform or draw blood. It takes your Superpower results (or any source's), normalises them into a memory, and produces one ranked next action, a watchlist, a clinician-ready question, and an outcome loop — with restraint built in.
You already have data and the real question is "what now?" — what to change, what to ignore, what to watch, and when a retest is actually worth it.
AMORTAL has no direct Superpower integration — you bring the data in by upload or manual entry.
The comparison, row by row
| Dimension | Superpower | AMORTAL |
|---|---|---|
| Best use case | Broad all-in-one health platform | Deciding what the data should change |
| Collection method | Lab draw, plus external data upload (as advertised) | No draws — works from results you already have |
| Lab partner / processing | Runs its own platform and panel (as advertised) | Lab-agnostic; vendor-neutral by design |
| Biomarker breadth | Broad panel (Superpower advertises 100+) | Doesn’t test; reads whatever you bring |
| Upload existing labs | Yes — its own platform accepts external data | Yes — bring Superpower or any other results in |
| Wearable integration | Connects wearables (as advertised) | Connects labs to Oura / Whoop / Apple Watch context |
| Clinician review | Care-team access (as advertised) | Clinician-compatible questions; not a clinician |
| Action plan depth | Protocols + an AI chat | One ranked next best action, plus restraint |
| Retesting cadence | Membership cadence + add-on tests | Tells you when not to retest yet |
| Result trend tracking | Trends + a biological-age readout in its platform | Longitudinal memory across providers and time |
| Abnormal-result handling | Flags + care-team access (as advertised) | Safety-gated; routes urgent flags to a clinician, never diagnoses |
| Data portability | Your data lives in Superpower | Cross-provider memory you carry with you |
| Cost model | Membership (verify current) | Decision layer — founding membership |
| Where AMORTAL fits | Broad platform data in | → ranked decision, watchlist, and outcome loop out |
Provider rows describe what Superpower publicly advertises as of June 2026 — pricing, marker count, care-team scope and add-ons change often, so confirm the current details on Superpower's own pages before buying. Sources are listed at the foot of this page.
Which one fits what you actually want
| What you want | Reach for |
|---|---|
| A broad, all-in-one platform with biomarkers, uploads and an AI chat | Superpower |
| One place to gather wearable data and external labs | Superpower |
| I already have results — tell me what to do next | AMORTAL |
| An auditable decision I can check later, not just an answer | AMORTAL |
| To know whether a protocol actually worked | AMORTAL (then retest via Superpower) |
| To know whether I should retest yet | AMORTAL |
| A clinician-ready question, not a treatment directive | AMORTAL |
| To avoid changing five things at once | AMORTAL |
How AMORTAL complements Superpower
The model is simple: let Superpower gather the data it gathers well, then run the result through a decision process instead of another dashboard.
- Bring the result in. Upload your Superpower report or enter the key markers — there's no direct integration, so you carry the data over.
- Normalise into memory. AMORTAL files each biomarker into a longitudinal record, not a one-off screen.
- Connect the context. Results are linked to your goals, symptoms, wearables, medications and constraints.
- Activate the standards. The guidelines and decision rules that actually apply to your situation switch on.
- Produce a Decision Contract. One change at a time, with the expected signal and the window written down in advance.
- Rank one Next Best Action. Not ten. The single highest-value move — which may be "do nothing yet."
- Set the watchlist. Markers worth re-checking get an expected direction and a recheck window.
- Close the loop. When the next Superpower panel or outcome signal arrives, AMORTAL checks whether the action worked — and keeps or discards it.
A decision loop, end to end
Here’s the same flow on a single example — illustrative numbers only, not a target or a reference range.
From a Superpower result to a tracked outcome
Your Superpower panel returns an elevated ApoB (say, in a range your care team flags as worth attention). On a dashboard — or in a chat reply — that's a red number and a vague nudge.
AMORTAL files it next to your prior lipids, your goals, your current medications and your wearable trends — so it's read as a trajectory, not a single dot.
One lever, not five. The expected signal (ApoB direction) and the window to see it are written down before anything changes.
Framed as a clinician-ready question — "given this trend, is [one specific lever] the right first move?" — not a treatment directive AMORTAL has no authority to give.
The marker goes on watch with an expected direction and a recheck window — so you retest when it's informative, not on a guess.
At the next Superpower draw, AMORTAL checks: did it move as expected? If yes, the change earns its place. If not, it's dropped — no story told over noise.
AMORTAL doesn't diagnose and isn't a substitute for your clinician — anything urgent goes to a professional, now.
Do you have a decision, or just an answer?
An AI chat can answer almost anything in the moment. The harder test is whether your setup produces a decision you can audit later. Tick what’s genuinely true of how you work today.
Is it an auditable decision?
Answer honestly about your current setup. A real decision should clear all three.
Tick what's true above
Your read on your current setup appears here.
A guide, not a guarantee. A chat is great for questions in the moment; a Decision Contract is what makes the answer auditable later.
Where Superpower is strongest — and where it isn’t
In fairness to both tools:
- Superpower is strongest when you want a broad, all-in-one platform — testing, uploads, wearable context, a biological-age readout and an AI chat gathered in one place — and you’ll actually engage with it.
- Superpower may be less ideal if your real bottleneck isn’t gathering data but deciding on the data you already have, or if a broad dashboard and a chat tempt you to over-react to every borderline marker.
- Verify before you buy. Marker count, price, what the care team includes and which add-ons exist all change — confirm the current details on Superpower’s own pages.
- A broad platform is a beginning, not an answer. Some results will need a clinician; neither a dashboard nor an AI chat should be read as a diagnosis.
Bring your results into a decision, not a dashboard
AMORTAL doesn’t need to be where you gather every test or connect every wearable. The stronger model is to let a broad platform like Superpower do the gathering, then use AMORTAL as the longitudinal decision system around those results. Upload a Superpower report, or enter the markers that matter. AMORTAL turns the result into memory, evaluates what’s still missing, ranks the next best action, sets a watchlist for the signals to expect, and later checks whether the action actually worked.
“Already have results from Superpower? Bring them into AMORTAL and ask: ‘What should I do next?’”
Sources
Provider claims describe what each company publicly advertised when this page was last fact-checked (26 June 2026). Pricing, marker counts, care-team scope and add-ons are volatile — verify on the official pages before purchase.
Superpower — membership, what's tested, uploads, wearable connections and care-team access (claims and pricing).
Educational only — this is not medical advice or a diagnosis. Talk to a licensed clinician about your own numbers, targets, and any treatment decisions.
Frequently asked
Can I use AMORTAL with my Superpower results?
Yes — that's the intended use. Superpower gives you a broad panel plus uploaded data and wearable context; you bring those results into AMORTAL by uploading the report or entering the key markers. AMORTAL normalises them into a longitudinal memory, connects them to your goals and context, and returns one ranked next action rather than another dashboard. AMORTAL has no direct Superpower integration; you carry the data over yourself.
Does AMORTAL replace Superpower?
No. They do different jobs. Superpower is a broad platform — it runs the testing, holds your uploads, connects wearables, and offers protocols and a care team. AMORTAL is a decision layer that sits on top of whatever health data you already have. Most people who use both keep Superpower for the data and the platform, and use AMORTAL to decide what each result should change, what to ignore, and when to retest.
Does AMORTAL order the test for me?
No. AMORTAL is not a lab or a testing platform and does not order or sell tests. It works from results you already have — from Superpower, a clinician, or any other lab. If a decision genuinely needs a test you don't have yet, AMORTAL will say so and name the one test that would actually change the decision, rather than nudging you to test everything.
What does AMORTAL do after my results come in?
It files them into your health memory, activates the standards that apply to you, and produces a Decision Contract: one next best action, the single signal you'd expect it to move, and the window to watch. It also creates watchlist items for markers worth re-checking later — and, importantly, will tell you when the right move is to change nothing yet.
Is a bigger panel always better?
Not automatically. A broad panel like Superpower's is genuinely useful for a baseline, but more markers also mean more borderline results that tempt over-reaction. AMORTAL evaluates whether a marker actually changes a realistic decision, whether the result is timely, whether a clinician should weigh in, and what downstream signal to watch — so breadth becomes useful instead of noisy.
What's the difference between Superpower's AI chat and AMORTAL's decision contracts?
A chat answers questions in the moment — useful, but conversational and easy to forget. A Decision Contract is the opposite: before you change anything, AMORTAL writes down one change, the single signal you'd expect it to move, and the window to watch — then, when the next result arrives, checks whether it actually happened. One gives you an answer; the other gives you an auditable, outcome-tracked decision you can review later.